Memantine

Common brands: Memantine Hydrochloride, Donepezil, Aspirin 325, Aspirin 81, Ecotrin

Top reporter: Amneal Pharmaceuticals Llc

Nonsteroidal Anti-inflammatory Drug [EPC]Atypical Antipsychotic [EPC]Benzodiazepine [EPC]Platelet Aggregation Inhibitor [EPC]Proton Pump Inhibitor [EPC]
13,230
Total Reports
7,263
Serious Reports
2,037
Death Reports
30
Reported Reactions
Death Report Ratio: High (15.40%)

Patient Demographics

Male
5,723
Female
6,159

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Memantine.

# Reaction Reports % of Total
1 FALL 962
7.2%
2 DEATH 892
6.7%
3 DRUG INEFFECTIVE 836
6.3%
4 OFF LABEL USE 758
5.7%
5 CONFUSIONAL STATE 718
5.4%
6 FATIGUE 622
4.7%
7 HALLUCINATION 605
4.5%
8 CONDITION AGGRAVATED 511
3.8%
9 ASTHENIA 479
3.6%
10 DIZZINESS 451
3.4%
11 SOMNOLENCE 451
3.4%
12 URINARY TRACT INFECTION 430
3.2%
13 NAUSEA 411
3.1%
14 DIARRHOEA 390
2.9%
15 PRODUCT DOSE OMISSION ISSUE 354
2.6%
16 AGITATION 350
2.6%
17 GAIT DISTURBANCE 349
2.6%
18 PNEUMONIA 334
2.5%
19 DEMENTIA 327
2.4%
20 DECREASED APPETITE 324
2.4%
21 VOMITING 323
2.4%
22 HEADACHE 321
2.4%
23 DRUG INTERACTION 312
2.3%
24 TREMOR 279
2.1%
25 DYSPNOEA 276
2.1%
26 BRADYCARDIA 275
2.1%
27 WEIGHT DECREASED 262
2.0%
28 HYPOTENSION 257
1.9%
29 CONSTIPATION 255
1.9%
30 INSOMNIA 254
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.